Waverton Investment Management LTD Abbott Laboratories Transaction History

Waverton Investment Management LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $3.07 Million - $3.61 Million	-29,000 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $274,920 - $333,870	-3,000 Reduced 9.38%	29,000 $3.16 Million
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $150,768 - $220,464	2,400 Added 8.11%	32,000 $2.53 Million
Q4 2019 Jan 23, 2020	BUY	$78.51 - $87.4 $2.32 Million - $2.59 Million	29,600 New	29,600 $2.57 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $4.26 Million - $4.75 Million	-54,298 Closed	0 $0

Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $132,562 - $150,173	-2,022 Reduced 3.59%	54,298 $3.93 Million
Q3 2018 Oct 04, 2018	BUY	$60.81 - $73.36 $2.2 Million - $2.65 Million	36,098 Added 178.51%	56,320 $4.13 Million
Q2 2018 Aug 22, 2018	BUY	$57.57 - $63.54 $1.16 Million - $1.28 Million	20,161 Added 33050.82%	20,222 $0
Q2 2018 Aug 21, 2018	SELL	$57.57 - $63.54 $1.16 Million - $1.28 Million	-20,161 Reduced 99.7%	61 $20,000
Q1 2018 Apr 06, 2018	BUY	$56.27 - $63.62 $1.14 Million - $1.29 Million	20,222 New	20,222 $1.21 Million

3,130

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Waverton Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Waverton Investment Management LTD with notifications on news.